Terazosin
Back to searchMolecule Structure
Scientific Name
Terazosin
Description of the Drug
Terazosin is an alpha-1 adrenergic antagonist used in the treatment of symptomatic benign prostatic hyperplasia and management of hypertension.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01162
http://www.drugbank.ca/drugs/DB01162
Brand Name(s)
Not Available
Company Owner(s)
Apnar Pharma Lp, Teva Pharmaceuticals Usa Inc, Heritage Pharma Labs Inc Dba Avet Pharmaceuticals Labs Inc, Ranbaxy Laboratories Ltd, Sandoz Inc, Abbott Laboratories Pharmaceutical Products Div, Jubilant Cadista Pharmaceuticals Inc, Mylan Technologies Inc, Mylan Pharmaceuticals Inc A Viatris Co, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Adrenergic receptor alpha-1 | PROTEIN FAMILY | ANTAGONIST | CHEMBL2094251 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL6528 | |||
PharmGKB | PA451612 | |||
Human Metabolome Database | HMDB0015293 | |||
DrugBank | DB01162 | |||
PubChem: Thomson Pharma | 14805011 | |||
PubChem | 5401 | |||
Mcule | MCULE-4030111564 | |||
LINCS | LSM-4997 | |||
Nikkaji | J19.669J | |||
BindingDB | 50033111 | |||
EPA CompTox Dashboard | DTXSID3023639 | |||
DrugCentral | 3584 | |||
ChemicalBook | CB2285511 | CB9285510 | CB22630517 | CB73360180 |
Guide to Pharmacology | 7302 | |||
rxnorm | TERAZOSIN HYDROCHLORIDE | TERAZOSIN | ||
KEGG Ligand | C07127 | |||
ChEBI | 9445 |